Professor David Adler is launching an initiative to bridge Israeli academia and the pharmaceutical industry, helping researchers turn biomedical discoveries into medicines, successful biotech companies and economic value through stronger industry collaboration | Read More in ynet – Culture.   Read More in Israel NOWlej.